Integra LifeSciences
IART
#4576
Rank
โ‚ฌ1.65 B
Marketcap
21,39 โ‚ฌ
Share price
-3.78%
Change (1 day)
-45.40%
Change (1 year)
Categories

P/E ratio for Integra LifeSciences (IART)

P/E ratio as of December 2024 (TTM): 18.2

According to Integra LifeSciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.1639. At the end of 2022 the company had a P/E ratio of 26.0.

P/E ratio history for Integra LifeSciences from 2001 to 2023

2005201020152020-1000-500500100015000companiesmarketcap.com

PE ratio at the end of each year

Year P/E ratio Change
202226.0-22.66%
202133.6-17.84%
202040.9-58.75%
201999.059.36%
201862.28.54%
201757.333.23%
201643.0-102.97%
2015< -1000-2888.61%
201452.0-173.44%
2013-70.7-366.29%
201226.6-16.41%
201131.849.17%
201021.30.55%
200921.2-40.43%
200835.62.65%
200734.7-18.64%
200642.647.73%
200528.8-55.5%
200464.8107.98%
200331.2113.56%
200214.6-40.74%
200124.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
52.7 190.36%๐Ÿ‡บ๐Ÿ‡ธ USA
20.1 10.53%๐Ÿ‡บ๐Ÿ‡ธ USA
-18.7-202.84%๐Ÿ‡บ๐Ÿ‡ธ USA
36.5 100.86%๐Ÿ‡บ๐Ÿ‡ธ USA
10.3-43.42%๐Ÿ‡บ๐Ÿ‡ธ USA
29.4 61.99%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
115 531.81%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.